Intercept Pharmaceuticals (ICPT) PT Lowered to $200 at Oppenheimer, Keeps 'Outperform'
Tweet Send to a Friend
Oppenheimer analyst Jay Olson lowered his price target on Intercept Pharmaceuticals (NASDAQ: ICPT) to $200.00 (from $250.00) but maintained an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
